Genome-wide association study of diabetic retinopathy in a Taiwanese population

Ophthalmology

Volumn 118, Issue 4, 2011, Pages 642-648

  Huang, Yu Chuen ^a,b   Lin, Jane Ming ^a,b   Lin, Hui Ju ^a,b   Chen, Ching Chu ^a,b   Chen, Shih Yin ^a,b   Tsai, Chang Hai ^c   Tsai, Fuu Jen ^a,b,c  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ANGIOGENESIS; ARHGAP22 GENE; ARTICLE; CAPILLARY PERMEABILITY; CHROMOSOME 10P; CHROMOSOME 10Q; CHROMOSOME 13Q; CHROMOSOME 1P; CHROMOSOME 5Q; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENDOTHELIUM CELL; FEMALE; GENE; GENE LOCATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; GENOTYPE; HS6ST3 GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYSM1 GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PLXDC2 GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN;

BLOOD PRESSURE; CASE-CONTROL STUDIES; CHIMERIN 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; EYE PROTEINS; FEMALE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; QUESTIONNAIRES; RECEPTORS, CELL SURFACE; TAIWAN;

EID: 79953329344     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2010.07.020     Document Type: Article

References (62)

1. Prokopenko I, McCarthy MI, Lindgren CM. Type 2 diabetes: new genes, new understanding. Trends Genet 2008;24:613-21.
2. He Z, King GL. Microvascular complications of diabetes. Endocrinol Metab Clin North Am 2004;33:215-38. (Pubitemid 38438432)
3. Caldwell RB, Bartoli M, Behzadian MA, et al. Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Diabetes Metab Res Rev 2003;19:442-55. (Pubitemid 37536961)
4. Moss SE, Klein R, Klein BE. The 14-year incidence of visual loss in a diabetic population. Ophthalmology 1998;105:998-1003. (Pubitemid 28268322)
5. Taylor HR, Keeffe JE. World blindness: a 21st century perspective. Br J Ophthalmol 2001;85:261-6.
6. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-20. (Pubitemid 34000785)
7. Jerneld B, Algvere P. Relationship of duration and onset of diabetes to prevalence of diabetic retinopathy. Am J Ophthalmol 1986;102:431-7. (Pubitemid 17183702)
8. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-12. (Pubitemid 30609442)
9. Hallman DM, Huber JC, Jr., Gonzalez VH, et al. Familial aggregation of severity of diabetic retinopathy in Mexican Americans from Starr County, Texas. Diabetes Care 2005;28:1163-8. (Pubitemid 40616629)
10. Rema M, Saravanan G, Deepa R, Mohan V. Familial clustering of diabetic retinopathy in South Indian Type 2 diabetic patients. Diabet Med 2002;19:910-6. (Pubitemid 35356916)
11. Hanson RL, Ehm MG, Pettitt DJ, et al. An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am J Hum Genet 1998;63:1130-8. (Pubitemid 30418584)
12. Imperatore G, Hanson RL, Pettitt DJ, et al. Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. Diabetes 1998;47:821-30. (Pubitemid 28201814)
13. Looker HC, Nelson RG, Chew E, et al. Genome-wide linkage analyses to identify Loci for diabetic retinopathy. Diabetes 2007;56:1160-6. (Pubitemid 46525074)
14. Hallman DM, Boerwinkle E, Gonzalez VH, et al. A genomewide linkage scan for diabetic retinopathy susceptibility genes in Mexican Americans with type 2 diabetes from Starr County, Texas. Diabetes 2007;56:1167-73. (Pubitemid 46525075)
15. dos Santos KG, Canani LH, Gross JL, et al. The -106CC genotype of the aldose reductase gene is associated with an increased risk of proliferative diabetic retinopathy in Caucasian-Brazilians with type 2 diabetes. Mol Genet Metab 2006;88:280-4.
16. Santos KG, Tschiedel B, Schneider J, et al. Diabetic retinopathy in Euro-Brazilian type 2 diabetic patients: relationship with polymorphisms in the aldose reductase, the plasminogen activator inhibitor-1 and the methylenetetrahydrofolate reductase genes. Diabetes Res Clin Pract 2003;61:133-6. (Pubitemid 37013658)
17. Wang Y, Ng MC, Lee SC, et al. Phenotypic heterogeneity and associations of two aldose reductase gene polymorphisms with nephropathy and retinopathy in type 2 diabetes. Diabetes Care 2003;26:2410-5. (Pubitemid 36993335)
18. Fujisawa T, Ikegami H, Kawaguchi Y, et al. Length rather than a specific allele of dinucleotide repeat in the 5′ upstream region of the aldose reductase gene is associated with diabetic retinopathy. Diabet Med 1999;16:1044-7. (Pubitemid 30051433)
19. Ichikawa F, Yamada K, Ishiyama-Shigemoto S, et al. Association of an (A-C)n dinucleotide repeat polymorphic marker at the 5′-region of the aldose reductase gene with retinopathy but not with nephropathy or neuropathy in Japanese patients with Type 2 diabetes mellitus. Diabet Med 1999;16:744-8. (Pubitemid 29459272)
20. Ko BC, Lam KS, Wat NM, Chung SS. An (A-C)n dinucleotide repeat polymorphic marker at the 5′ end of the aldose reductase gene is associated with early-onset diabetic retinopathy in NIDDM patients. Diabetes 1995;44:727-32.
21. Kador PF, Kinoshita JH. Role of aldose reductase in the development of diabetes-associated complications. Am J Med 1985;79:8-12. (Pubitemid 16213222)
22. Abhary S, Burdon KP, Gupta A, et al. Common sequence variation in the VEGFA gene predicts risk of diabetic retinopathy. Invest Ophthalmol Vis Sci 2009;50:5552-8.
23. Kangas-Kontio T, Vavuli S, Kakko SJ, et al. Polymorphism of the manganese superoxide dismutase gene but not of vascular endothelial growth factor gene is a risk factor for diabetic retinopathy. Br J Ophthalmol 2009;93:1401-6.
24. Churchill AJ, Carter JG, Ramsden C, et al. VEGF polymorphisms are associated with severity of diabetic retinopathy. Invest Ophthalmol Vis Sci 2008;49:3611-6.
25. Uthra S, Raman R, Mukesh BN, et al. Association of VEGF gene polymorphisms with diabetic retinopathy in a south Indian cohort. Ophthalmic Genet 2008;29:11-5. (Pubitemid 351431242)
26. Suganthalakshmi B, Anand R, Kim R, et al. Association of VEGF and eNOS gene polymorphisms in type 2 diabetic retinopathy. Mol Vis 2006;12:336-41.
27. Awata T, Kurihara S, Takata N, et al. Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes. Biochem Biophys Res Commun 2005;333:679-85. (Pubitemid 40854214)
28. Ray D, Mishra M, Ralph S, et al. Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes. Diabetes 2004;53:861-4. (Pubitemid 38270661)
29. Awata T, Inoue K, Kurihara S, et al. A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 2002;51:1635-9. (Pubitemid 34826636)
30. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480-7. (Pubitemid 24356306)
31. Prasad P, Tiwari AK, Kumar KM, et al. Association of TGF-beta1, TNFalpha, CCR2 and CCR5 gene polymorphisms in type-2 diabetes and renal insufficiency among Asian Indians. BMC Med Genet 2007;8:20.
32. Buraczynska M, Baranowicz-Gaszczyk I, Borowicz E, Ksiazek A. TGF-beta1 and TSC-22 gene polymorphisms and susceptibility to microvascular complications in type 2 diabetes. Nephron Physiol 2007;106:69-75.
33. Wong TY, Poon P, Chow KM, et al. Association of transforming growth factor-beta (TGF-beta) T869C (Leu 10Pro) gene polymorphisms with type 2 diabetic nephropathy in Chinese. Kidney Int 2003;63:1831-5. (Pubitemid 36513330)
34. Beranek M, Kankova K, Benes P, et al. Polymorphism R25P in the gene encoding transforming growth factor-beta (TGF-beta1) is a newly identified risk factor for proliferative diabetic retinopathy. Am J Med Genet 2002;109:278-83.
35. Pascal MM, Forrester JV, Knott RM. Glucose-mediated regulation of transforming growth factor-beta (TGF-beta) and TGF-beta receptors in human retinal endothelial cells. Curr Eye Res 1999;19:162-70. (Pubitemid 29396557)
36. Awata T, Neda T, Iizuka H, et al. Endothelial nitric oxide synthase gene is associated with diabetic macular edema in type 2 diabetes. Diabetes Care 2004;27:2184-90. (Pubitemid 39167183)
37. Ezzidi I, Mtiraoui N, Mohamed MB, et al. Endothelial nitric oxide synthase Glu298Asp, 4b/a, and T-786C polymorphisms in type 2 diabetic retinopathy. Clin Endocrinol (Oxf) 2008;68:542-6. (Pubitemid 351388711)
38. Chen Y, Huang H, Zhou J, et al. Polymorphism of the endothelial nitric oxide synthase gene is associated with diabetic retinopathy in a cohort of West Africans. Mol Vis 2007;13:2142-7. (Pubitemid 350200388)
39. Warpeha KM, Xu W, Liu L, et al. Genotyping and functional analysis of a polymorphic (CCTTT)(n) repeat of NOS2A in diabetic retinopathy. FASEB J 1999;13:1825-32. (Pubitemid 29473345)
40. Tong Z, Yang Z, Patel S, et al. Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. Proc Natl Acad Sci U S A 2008;105:6998-7003. (Pubitemid 351754519)
41. Petrovic MG, Hawlina M, Peterlin B, Petrovic D. BglII gene polymorphism of the alpha2beta1 integrin gene is a risk factor for diabetic retinopathy in Caucasians with type 2 diabetes. J Hum Genet 2003;48:457-60. (Pubitemid 37295601)
42. Matsubara Y, Murata M, Maruyama T, et al. Association between diabetic retinopathy and genetic variations in alpha2beta1 integrin, a platelet receptor for collagen. Blood 2000;95:1560-4. (Pubitemid 30120813)
43. Kamiuchi K, Hasegawa G, Obayashi H, et al. Intercellular adhesion molecule-1 (ICAM-1) polymorphism is associated with diabetic retinopathy in Type 2 diabetes mellitus. Diabet Med 2002;19:371-6. (Pubitemid 34534211)
44. Liu L, Yu Q, Wang H, et al. Association of intercellular adhesion molecule 1 polymorphisms with retinopathy in Chinese patients with Type 2 diabetes. Diabet Med 2006;23:643-8. (Pubitemid 43830065)
45. Abhary S, Hewitt AW, Burdon KP, Craig JE. A systematic meta-analysis of genetic association studies for diabetic retinopathy. Diabetes 2009;58:2137-47.
46. Wilkinson CP, Ferris FL, III, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003;110:1677-82. (Pubitemid 37025422)
47. Pan WH, Fann CS, Wu JY, et al. Han Chinese cell and genome bank in Taiwan: purpose, design and ethical considerations. Hum Hered 2006;61:27-30. (Pubitemid 43800650)
48. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5. (Pubitemid 40202029)
49. Zhu P, Zhou W, Wang J, et al. A histone H2A deubiquitinase complex coordinating histone acetylation and H1 dissociation in transcriptional regulation. Mol Cell 2007;27:609-21. (Pubitemid 47238636)
50. Cope GA, Suh GS, Aravind L, et al. Role of predicted metalloprotease motif of Jab1/Csn5 in cleavage of Nedd8 from Cul1. Science 2002;298:608-11. (Pubitemid 35215316)
51. Verma R, Aravind L, Oania R, et al. Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome. Science 2002;298:611-5. (Pubitemid 35215317)
52. Sanna-Cherchi S, Caridi G, Weng PL, et al. Localization of a gene for nonsyndromic renal hypodysplasia to chromosome 1p32-33. Am J Hum Genet 2007;80:539-49.
53. Katoh M, Katoh M. Identification and characterization of ARHGAP24 and ARHGAP25 genes in silico. Int J Mol Med 2004;14:333-8.
54. Sanz-Moreno V, Gadea G, Ahn J, et al. Rac activation and inactivation control plasticity of tumor cell movement. Cell 2008;135:510-23.
55. Larance M, Rowland AF, Hoehn KL, et al. Global phosphoproteomics identifies a major role for AKT and 14-3-3 in regulating EDC3. Mol Cell Proteomics 2010;9:682-94.
56. Carson-Walter EB, Watkins DN, Nanda A, et al. Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res 2001;61:6649-55. (Pubitemid 32896479)
57. Dupuis J, Langenberg C, Prokopenko I, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010;42:105-16.
58. Visser R, Gijsbers A, Ruivenkamp C, et al. Genome-wide SNP array analysis in patients with features of sotos syndrome. Horm Res Paediatr 2010;73:265-74.
59. Habuchi H, Tanaka M, Habuchi O, et al. The occurrence of three isoforms of heparan sulfate 6-O-sulfotransferase having different specificities for hexuronic acid adjacent to the targeted N-sulfoglucosamine. J Biol Chem 2000;275:2859-68. (Pubitemid 30082060)
60. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, et al. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989;32:219-26. (Pubitemid 19136363)
61. Kamimura K, Fujise M, Villa F, et al. Drosophila heparan sulfate 6-O-sulfotransferase (dHS6ST) gene. Structure, expression, and function in the formation of the tracheal system. J Biol Chem 2001;276:17014-21.
62. Nogami K, Suzuki H, Habuchi H, et al. Distinctive expression patterns of heparan sulfate O-sulfotransferases and regional differences in heparan sulfate structure in chick limb buds. J Biol Chem 2004;279:8219-29. (Pubitemid 38294714)